Research, treatment, awareness and prevention of gynaecological cancer | GO Research Fund
Home - Research, treatment, awareness and prevention of gynaecological cancer | GO Research Fund About Us - Research, treatment, awareness and prevention of gynaecological cancer | GO Research Fund Donations - Research, treatment, awareness and prevention of gynaecological cancer | GO Research Fund News & Information - Research, treatment, awareness and prevention of gynaecological cancer | GO Research Fund Medical Information - Research, treatment, awareness and prevention of gynaecological cancer | GO Research Fund Supporters - Research, treatment, awareness and prevention of gynaecological cancer | GO Research Fund Contact Us - Research, treatment, awareness and prevention of gynaecological cancer | GO Research Fund
About Go Research Fund

What is the GO Research Fund?

The GO Research Fund, a sub-entity of the Royal Hospital for Women Foundation Limited, a registered charity, raises money for awareness, treatment, education and research into gynaecological cancers.

The GO Research Fund is dependent on the generous donations from independent sources to support the vital cancer research being undertaken.

What do we do?

The GO Research Fund’s major allocation is its commitment to the Ovarian Cancer Project, a collaboration between the Gynaecological Cancer Centre at the Royal Hospital for Women and the Cancer Research Program at the Garvan Institute of Medical Research. This brings together an internationally renowned treatment centre and an internationally renowned research centre.

The major aim is to develop a blood-based screening test to diagnose ovarian cancer while it is still confined to the ovaries. We are the only centre in Australia focusing on serous ovarian cancer, which is the most common ovarian cancer and the one with the worst prognosis.

Why is this necessary?

Women have a 1 in 20 chance of getting some type of gynaecological cancer in their lifetime.
Ovarian cancer is the most fatal gynaecological malignancy. It is often called “The Silent Killer”.
Ovarian cancer is expected to increase by 23% within Australia by 2011.
The 5 year survival for ovarian cancer is only 40% compared to a 5 year survival of 85% for breast cancer.
The reason for the poor prognosis is that 70% of women are diagnosed with advanced stage disease.
80% of these women with advanced disease will die within 5 years.
850 women die of ovarian cancer every year in Australia – a woman dies every 10 hours from this disease.
When ovarian cancer is detected early it has an 85–90% survival rate.
Early stage ovarian cancer can often be cured by surgery alone without the need for chemotherapy.

What is our vision?

To find a simple blood test that will allow all women to be screened for ovarian cancer and diagnosed while the disease is in its early stages
.
To find more effective treatments for all gynaecological cancers.

How can you help?

Commit to a pledged donation to ensure the continued work of our researchers. This can be done online at our website or through the attached donation form.
Help us by spreading the word about what we do and why it is so important for all women across Australia. Raise awareness within your community or workplace about the lack of an ovarian cancer screening test and work that the GO Research Fund is doing to resolve this.
Bequests and ‘In-Memoriam’ gifts ensure this work carries on for generations. “The greatest gift you can give is the gift of life”.
Volunteer your time to assist us on our charity days or with our mail out. If you can offer your services to help

back to top

About Us
History
Executive Committee
Research Team

Gynaecological cancer research, treatment, awareness and prevention | GO Research Fund

Gynaecological cancer research, treatment, awareness and prevention | GO Research Fund

Gynaecological cancer research, treatment, awareness and prevention | GO Research Fund

  Copyright 2009 Go Research Fund | Volunteers | Privacy Policy | Sitemap
 
   
Royal Hospital For Women Foundation Link Click to go back to homepage